Why CLVT rose 20.8% on Nov 3 2026: earnings beat

THE SESSION

• 09:30 ETOpened at $1.62, -2.4% on the previous close of $1.66
• 09:30 ETRegular-session low, $1.60
• 14:15 ETRegular-session high, $2.10
• 15:59 ETLast trade of the regular session, $2.08, +25.6% on the previous close of $1.66
• Volume: 10.8M shares in regular hours, 69K before the open

CLVT opened at $1.62 and slipped to $1.60, then reversed higher through the session to reach $2.10 by 14:15 and finish at $2.08, up 25.6% from the previous close. TapeRank tied the move to a modest Q3 adjusted EPS beat and positive strategic commentary in the earnings update, while noting that the rally looked stretched because Clarivate cut FY2026 sales guidance and projected Q4 sales below consensus despite improved profitability and debt reduction. No halts were recorded.

WRITTEN TUE NOV 3 2026 16:00 ET BY OPENAI/GPT-5.6-LUNA FROM THE FACTS ON THIS PAGE

FILINGS AND NEWS · 24H BEFORE THE MOVE

• 09:07 ETClarivate Q3 2026 Earnings Call TranscriptBenzinga
• 08:05 ET10-Q — Quarterly reportSEC 10-Q
• 08:04 ET8-K — Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and ExhibitsSEC 8-K
• 06:10 ETClarivate Lowers FY2026 GAAP EPS Guidance from $(0.64)-$(0.54) to $(0.65)-$(0.62) vs $(0.46) EstBenzinga
• 06:09 ETClarivate Sees Q4 Adj EPS $0.14-$0.18 vs $0.19 Est; Sees Sales $490.000M-$510.000M vs $562.824M EstBenzinga
• 06:09 ETClarivate Narrows FY2026 Adj EPS Guidance from $0.70-$0.80 to $0.73-$0.77 vs $0.74 Est; Lowers FY2026 Sales Guidance from $2.300B-$2.420B to $1.965B-$1.985B vs $2.304B EstBenzinga